DLD Asset Management »

Translational Dev Acquisitio shares owned by DLD Asset Management

Quarter-by-quarter ownership of Translational Dev Acquisitio (TDACW) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Translational Dev Acquisitio

Tip: Access up to 7 years of quarterly data

All positions including Translational Dev Acquisitio held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Translational Dev Acquisitio by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $20k 97k 0.20

More positions owned by DLD Asset Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Centrus Energy Corp Cl A Put Option (LEU)
Echostar Corp Note 3.875%11/3 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Ishares Tr Ishares Biotech Put Option (IBB)
Spirit Aerosystems Note 3.250%11/0 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Dropbox Note 3/0 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Bristol Myers Squibb (BMY)

View all positions for DLD Asset Management

Top funds holding Translational Dev Acquisitio

Shaolin Capital Management
Magnetar Financial
CSS
CNH Partners
Verition Fund Management
Healthcare Of Ontario Pension Plan Trust Fund
Polar Securities
LMR Partners
Hudson Bay Capital Management
Tenor Capital Management
Linden Advisors
K2 Principal Fund
Rivernorth Capital Management
Bnp Paribas Arbitrage, Snc
Toronto-Dominion Bank

View all funds holding Translational Dev Acquisitio